中国医药导报
中国医药期刊欢迎您 今天是   2025年4月6日星期天
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  临床医学-肿瘤 本期目录 | 过刊浏览 | 高级检索 |
补中益气汤对老年晚期消化系统恶性肿瘤骨髓抑制及生活质量的影响
朱明辉      曹静      周玺      李雁飞▲
江苏省人民医院老年消化科,江苏南京   210029
Effect of Buzhong Yiqi Decoction on bone marrow suppression and quality of life in elderly patients with advanced digestive system malignant tumors
ZHU Minghui   CAO Jing   ZHOU Xi   LI Yanfei▲
Department of Elderly Digestion, Jiangsu Provincial People’s Hospital, Jiangsu Province, Nanjing   210029, China
全文: PDF (726 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探究补中益气汤对老年晚期消化系统恶性肿瘤骨髓抑制及生活质量的影响。 方法 选取2019年1月至2022年4月江苏省人民医院接诊的83例老年晚期消化系统恶性肿瘤患者,采用随机数字表法将其分为对照组(41例,XELOX化疗)和观察组(42例,XELOX化疗+补中益气汤)。统计并比较两组化疗后4周的临床疗效及化疗后1周的骨髓抑制情况,统计并比较两组化疗前及化疗后1周的生活质量和免疫水平。记录化疗期间的不良反应发生情况。 结果 化疗后4周,观察组疗效优于对照组,差异有统计学意义(P<0.05)。化疗后1周,观察组骨髓抑制率Ⅱ级及以上的发生率低于对照组,差异有统计学意义(P<0.05)。化疗后1周,对照组卡氏功能状态(KPS)评分低于本组治疗前,观察组KPS评分高于本组治疗前,两组免疫球蛋白(Ig)M、IgG、IgA水平均高于治疗前,且观察组KPS评分、IgM、IgG、IgA均高于对照组,差异有统计学意义(P<0.05)。两组治疗期间恶心呕吐、腹泻、脱发发生率比较,差异无统计学意(P>0.05)。 结论 补中益气汤可以提高老年晚期消化系统恶性肿瘤患者的临床疗效,降低骨髓抑制程度,极大地改善了患者的生活质量与免疫能力,可以在临床治疗中推广使用。

服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
朱明辉 曹静 周玺 李雁飞▲
关键词 补中益气汤消化系统恶性肿瘤骨髓抑制生活质量免疫水平    
Abstract:Objective To explore the effect of Buzhong Yiqi Decoction on bone marrow suppression and quality of life in elderly patients with advanced digestive system malignant tumors. Methods Eighty-three elderly patients with advanced digestive system malignant tumor admitted to Jiangsu Provincial People’s Hospital from January 2019 to April 2022 were selected and divided into control group (41 cases, XELOX chemotherapy) and observation group (42 cases, XELOX chemotherapy + Buzhong Yiqi Decoction) by random number table method. The clinical efficacy of four weeks after chemotherapy and the myelosuppression of one week after chemotherapy were analyzed and compared between the two groups. The quality of life and immune level before and one week after chemotherapy were analyzed and compared between the two groups. The occurrence of adverse reactions during chemotherapy was recorded. Results At four weeks after chemotherapy, the curative effect of the observation group was better than that of the control group, the difference was statistically significant (P<0.05). One week after chemotherapy, the incidence of grade Ⅱ and above myelosuppression rate in observation group was lower than that in control group, and the difference was statistically significant (P<0.05). One week after chemotherapy, the Kanofsky performance status (KPS) score of control group was lower than that of control group before treatment, the KPS score of observation group was higher than that of observation group before treatment, and the levels of immunoglobulin (Ig) M, IgG, and IgA in both groups were higher than those before treatment, KPS score, IgM, IgG, and IgA in the observation group were higher than those in the control group, and the differences were statistically significant (P<0.05). There were no significant differences in the incidence of nausea, vomiting, diarrhea, and alopecia between the two groups (P>0.05). Conclusion Buzhong Yiqi Decoction can improve the clinical efficacy of elderly patients with advanced digestive system malignant tumors, reduce the degree of bone marrow suppression, greatly improve the quality of life and immune capacity of patients, and can be widely used in clinical treatment.
Key wordsBuzhong Yiqi Decoction    Digestive system malignant tumors    Bone marrow suppression    Quality of life    Immune level
    
基金资助:江苏省自然科学基金资助项目(BK20200265)。
通讯作者: ▲通讯作者   
引用本文:   
朱明辉 曹静 周玺 李雁飞▲. 补中益气汤对老年晚期消化系统恶性肿瘤骨髓抑制及生活质量的影响[J]. 中国医药导报, 2023, 20(5): 90-93,97.
ZHU Minghui CAO Jing ZHOU Xi LI Yanfei▲. Effect of Buzhong Yiqi Decoction on bone marrow suppression and quality of life in elderly patients with advanced digestive system malignant tumors. 中国医药导报, 2023, 20(5): 90-93,97.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.05.21     或     https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I5/90

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司